Next Article in Journal
Clostridium butyricum MIYAIRI 588 Increases the Lifespan and Multiple-Stress Resistance of Caenorhabditis elegans
Previous Article in Journal
Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances
Previous Article in Special Issue
Simultaneous miRNA and mRNA Transcriptome Profiling of Differentiating Equine Satellite Cells Treated with Gamma-Oryzanol and Exposed to Hydrogen Peroxide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome

1
Research Group on Community Nutrition and Oxidative Stress, Science Laboratory of Physical Activity, Department of Fundamental Biology and Health Sciences, University of Balearic Islands, 07122 Palma de Mallorca, Spain
2
CIBER CB12/03/30038 Fisiopatología de la Obesidad la Nutrición, CIBEROBN, Instituto de Salud Carlos III (ISCIII), University of Balearic Islands, 07122 Palma de Mallorca, Spain
*
Author to whom correspondence should be addressed.
Submission received: 30 October 2018 / Revised: 28 November 2018 / Accepted: 1 December 2018 / Published: 5 December 2018

Abstract

:
Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) can exert opposed effects depending on the dosage: low levels can be involved in signalling and adaptive processes, while higher levels can exert deleterious effects in cells and tissues. Our aim was to emulate a chronic ex vivo oxidative stress situation through a 2 h exposure of immune cells to sustained H2O2 produced by glucose oxidase (GOX), at high or low production rate, in order to determine dissimilar responses of peripheral blood mononuclear cells (PBMCs) and neutrophils on ROS and cytokine production, and mitochondrial dynamics-related proteins, pro/anti-inflammatory and anti-oxidant gene expression. Immune cells were obtained from subjects with metabolic syndrome. H2O2 at low concentrations can trigger a transient anti-inflammatory adiponectin secretion and reduced gene expression of toll-like receptors (TLRs) in PBMCs but may act as a stimulator of proinflammatory genes (IL6, IL8) and mitochondrial dynamics-related proteins (Mtf2, NRF2, Tfam). H2O2 at a high concentration enhances the expression of pro-inflammatory genes (TLR2 and IL1β) and diminishes the expression of mitochondrial dynamics-related proteins (Mtf1, Tfam) and antioxidant enzymes (Cu/Zn SOD) in PBMCs. The GOX treatments produce dissimilar changes in immune cells: Neutrophils were more resistant to H2O2 effects and exhibited a more constant response in terms of gene expression than PBMCs. We observe emerging roles of H2O2 in mitochondrial dynamics and redox and inflammation processes in immune cells.

1. Introduction

Metabolic syndrome is a constellation of metabolic abnormalities including hypertension, hyperglycaemia, abdominal fatness, and dyslipidemia. Patients suffering from metabolic syndrome exhibit an evident redox imbalance and an inflammatory status that affect the cellular responses and subclasses of immune cells [1,2,3,4]. Peripheral blood leukocyte subclasses from metabolic syndrome patients have a different phenotype compared to non-obese patients, which includes clinical biomarkers that largely reflect already manifested comorbidities [5], and are correlated with subcutaneous adipose tissue macrophages participating in the adipose tissue inflammation [6]. Obesity, a feature of metabolic syndrome, is commonly associated with chronic low-grade inflammation with permanently increased levels of reactive oxygen species (ROS) [7,8,9], such as hydrogen peroxide (H2O2), superoxide anion (O2·−), hydroxyl radical (OH·), and hypochlorous acid (HClO) [10]. H2O2, due to its relative stability, mild chemical reactivity, and ability to diffuse [11], is an important metabolite involved in sensing, modulation, and signalling of redox metabolism reactions and processes in the cells [12]. Mounting evidence establishes that these H2O2–dependent signalling events are triggered by the activation of diverse cell surface receptors [13]. H2O2 exhibits the ability to specifically oxidise proteins [14,15,16] that activate cascades of downstream responses that lead to various metabolic outputs in the cells [17,18,19,20,21]. According to the downstream pathways that are triggered, homeostatic, pathological, or protective cascades can be activated [22]. Physiological redox signalling is characterized by reversible oxido-reductive modifications [23] of specific cysteine residues, such as thiolate anion (Cys-S-), susceptible to oxidation. The two-electron oxidation of a thiolate by H2O2 yields sulfenic acid, which is implicated in a number of important biochemical transformations. Cysteines from several transcription factors (e.g., NF-κB), or proteins involved in cell signalling or metabolism (e.g., GAPDH, glutathione reductase, tyrosine phosphatases, kinases, and proteases) can be turned into sulfenic acid [24,25,26]. The reaction of ROS with protein thiols provides a mechanism by which cells can “sense” changes in the redox balance. Understanding the molecular mechanisms and the dosage by which H2O2 exerts the beneficial/adaptive responses more likely than the negative/pathological ones has far-reaching practical significance since several pathological states including, including metabolic syndrome, are characterized by altered redox biology [16].
To ascertain the role of cellular oxidants in physiological and pathological processes, it is imperative to be able to distinguish and characterize those species involved and monitor its levels in the biological system of interest [27]. Most phenotypic and signalling studies of cellular responses to H2O2 are designed using extracellular addition, either with a bolus or with sustained generation [28] using glucose oxidase [19]. Peripheral blood mononuclear cells (PBMCs), consisting of T cells, B cells and monocytes, provide an ideal culture model for the study of inflammation and immunity. Neutrophils also serve as cellular models as well considering their various anti-pathogen functions, among others, in an inflammation environment. We aim to emulate a chronic ex vivo oxidative stress situation through the continuous exposure of immune cells, from patients with metabolic syndrome, to H2O2 produced by glucose oxidase (GOX). The experimental procedure is designed to induce an oxidative stress status in order to distinguish those situations in which H2O2 generates oxidative imbalance or promotes beneficial responses. We wanted to bring to light the genes whose expression is upregulated when immune cells are exposed to different H2O2 concentrations. Furthermore, we aimed to evidence the effects of H2O2 on the expression of the ROS and the cytokine production.

2. Materials and Methods

2.1. Study Design

The present study is a cross-sectional analysis on baseline samples within the frame of the PREDIMED-Plus study, a 6-year multicentre, parallel-group, randomized trial conducted in Spain to assess the effect on cardiovascular disease morbimortality of an intensive weight loss intervention programme based on an energy-restricted traditional MedDiet (erMedDiet), physical activity promotion, and behavioural support, in comparison with a typical care intervention only with energy-unrestricted MedDiet (control group). Details of the study protocol can be found elsewhere [29]. The trial was registered in 2014 at the International Standard Randomized Controlled Trial (ISRCT [30]) with number 89898870.

2.2. Participants’ Characteristics

A total of 34 participants from the randomized, multicentre, clinical trial with parallel groups with metabolic syndrome (PREDIMED-Plus) were enrolled in this study. Inclusion criteria included men aged 55–75 and women between 60–75 years old, with a BMI ≥ 27 and < 40 kg/m2, that meet at least 3 criteria for metabolic syndrome according to the updated harmonized criteria of the International Diabetes Federation and the American Heart Association and National Heart, Lung, and Blood Institute [31]. Exclusion Criteria were (a) inability or unwillingness to give informed consent, (b) documented history of previous cardiovascular disease, (c) active cancer or a history of malignant tumours in the last 5 years, and (d) impossibility to follow a recommended diet or to carry out physical activity. All participants were informed of the purpose and the implications of the study, and informed consent was obtained from all subjects. All participants were studied at the beginning of the trial; no intervention was yet applied to these subjects. The study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures were approved by the Research Ethics Committee of the Balearic Islands (reference no. 2251/14 PI).

2.3. Cell Isolation and Cell Viability Test

Venous blood samples were obtained from the antecubital vein of participants in the study in suitable vacutainers with ethylenediaminetetraacetic acid (EDTA) as an anticoagulant in fasting conditions. Cell counts were determined in an automatic flow cytometer analyzer Technicon H2 (Bayer, Leverkusen, Germany) VCS system. The PBMC and neutrophil fractions were purified from fresh whole blood and isolated following the protocol described previously [32] using Ficoll-Paque PLUS reagent (GE Healthcare, Chalfont St Giles, UK) [33,34]. Briefly, 6 mL of blood was carefully introduced on 4 mL of Ficoll (proportion of 1.5:1) and was then centrifuged at 900× g, at 4 °C for 30 min. The plasma and the Ficoll phases were discarded and the PBMCs layer was washed twice with phosphate-buffered saline (PBS), pH 7.4., and centrifuged for 10 min at 1000× g, 4 °C. The precipitate containing the erythrocytes and neutrophils was incubated at 4 °C with 0.15 mol/L of ammonium chloride to haemolyse the erythrocytes. The suspension was centrifuged at 750× g, at 4 °C for 10 min and the supernatant was then discarded. The neutrophil phase at the bottom was washed first with ammonium chloride and then with PBS. Cell lysates for RNA purification were stored at −80 °C with 1 mL of Tripure Isolation Reagent® (Roche Diagnostics, Mannheim, Germany) until biochemical analysis, while a fresh aliquot was used for ROS determination. Cell viability was assessed using a crystal violet nuclear staining assay [35]. Violet dye binds to proteins and DNA of living cells. Cells that undergo cell death lose their adherence to culture surface and are subsequently lost from the population of cells, reducing the amount of crystal violet staining in a culture. Briefly, 20 µL of 0.5% crystal violet solution in 30% acetic acid was added to 500 µL of suspension of cells and incubate for 10 min at room temperature. Cells were centrifuged (1000× g, 10 min) and washed thrice with PBS, until the dye stopped coming off. 100 µL of ethanol were added and all the volume was then transferred onto a 96-well microplate and absorbance at 570 nm was recorded in a microplate reader (Bio-Tek Instruments, Inc., Winooski, VT, USA)

2.4. Cell Treatments and Experimental Design

All treatments were performed in 2 mL sterilized tubes containing 3 × 106 PBMCs/mL and 3.5 × 106 neutrophils/mL. Cells were resuspended in 2 mL of RPMI-1640 medium with glucose (2 g/L), l-glutamine and NaHCO3. Cells were incubated at 37 °C in a humidified atmosphere for 2 h in the absence and in the presence of two different concentrations (high and low) of glucose oxidase (GOX), following a procedure previously described [36,37]. Lyophilized glucose oxidase (GOX) type X-S from Aspergillus niger (~75% protein, 138,370 U/g solid, Sigma-Aldrich) was used to generate H2O2 (one unit of GOX oxidizes 1.0 μmole of β-D-glucose to D-glucono-δ-lactone and H2O2 per min at pH 5.1 at 35 °C, equivalent to an O2 uptake of 22.4 μL per min, according to the manufacturer’s instructions). GOX was added at concentrations 1 and 0.1 µg solid/mL culture medium (high and low treatment, respectively) in PBMCs. GOX was added at concentrations 15 and 5 µg solid/mL culture medium (high and low treatment, respectively) in neutrophils.

2.5. Calibration of H2O2 to Cell Exposure

The calibration of H2O2 exposition was monitored colourimetrically in PBMCs and neutrophils cultured in the presence of high or low GOX activities. PBMCs were incubated as indicated above in presence of high (1 µg solid/mL culture medium) or low (0.1 µg solid/mL culture medium) GOX amounts. Neutrophils were incubated as indicated above in presence of high (15 µg solid/mL culture medium) or low (5 µg solid/mL culture medium) GOX amounts. Aliquots of cell culture were taken at different incubation times, and deproteinized with acetone [38,39] at 4 °C in order to stop the H2O2 production by the enzyme. The H2O2 levels were determined in the deproteinization supernatants (centrifugation conditions: 900× g at 4 °C for 5 min) by using horseradish peroxidase and tetramethylbenzidine (TMB) and measuring the absorbance at 450 nm [36,40]. H2O2 concentration was calculated with a standard curve of known concentrations. Figure 1 summarizes the process to attain the steady state of H2O2 used in our experimental model. The steady state is a consequence of the extracellular production of hydrogen peroxide by glucose oxidase in the presence of glucose, and of the elimination of H2O2 through the enzymatic mechanisms within the neutrophils and PBMCs. When the steady state is attained, the rate of production and elimination is equal.

2.6. Stimulated PBMCs and Neutrophils H2O2 Production

After the 2 h incubation at 37 °C, H2O2 production by PBMCs and neutrophils was measured using 2,7-dichlorofluorescin-diacetate (DCFH-DA) as an indicator [41,42]. A stock solution of DCFH-DA (2.05 mM) in ethanol was prepared and stored at −20 °C until analysis. Hanks’ Balanced Salts Medium was prepared in a relation of 9.8 g/L water. H2O2 production in PBMCs and neutrophils was measured before and after stimulation with lipopolysaccharide (LPS) (100 µg/mL PBS) from Escherichia coli (Sigma-Aldrich, St. Louis, MO, USA) or Zymosan A (ZYM) (1 mg/mL PBS) from Saccharomyces cerevisiae (Sigma-Aldrich). A total of 50 µL of LPS or ZYM prepared in PBS was added to the wells. DCFH-DA in ethanol was diluted in Hanks’ Balanced Salts Medium (relation 30 µL DCFH-DA/mL Hanks’) and added to a 96-well microplate containing 50 µL of cell suspension (containing about 6 × 105 cells). The fluorescence (Ex, 480 nm; Em, 530 nm) was recorded at 37 °C for 60 min in FLx800 Microplate Fluorescence Reader (Bio-tek Instruments, Inc.) by punctual ultraviolet light exposures and emission readings were recorded every minute (60 total readings). H2O2 concentration was calculated by measuring fluorescence of a standard curve of known H2O2 concentration after its reaction with DCFH-DA, in the same conditions as the samples.

2.7. RNA Isolation and mRNA Gene Expression

mRNA expressions were determined by Real Time PCR (RT-PCR) based on the incorporation of a fluorescent reporter dye and using human 18S ribosomal as the reference gene [43]. For this purpose, the total mRNA from PBMCs and neutrophils was isolated by extraction with Tripure Isolation Reagent® (Roche Diagnostics, Mannheim, Germany) following a procedure previously described [44,45]. cDNA was synthesized from 1 µg total RNA using 50 units of Expand Reverse Transcriptase (Roche Diagnostics, Germany) and 20 pmol of oligo (dT) for 60 min at 37 °C in a final volume of 10 μL, according to the manufacturer’s instructions. Semiquantitative PCR of the resulting cDNA (3 μL) was amplified using the LightCycler® 480 instrument (Roche Diagnostics, Mannheim, Germany) with FastStart DNA MasterPLUS SYBR™ Green I kit (Roche Diagnostics, Mannheim, Germany). The specific primers and amplification conditions used for each gene are presented in Table 1. Target cDNAs were amplified as follows: one cycle at 95 °C for 10 min, followed by 45 cycles of amplification (95 °C for 10 s; specific annealing temperature for 10 s; 72 °C for 15 s). mRNA levels in the control situation (no glucose oxidase in the medium) were arbitrarily referred to as 1.

2.8. Cytokine Determination

Adiponectin, IL6, and TNFα from cell incubation supernatants were determined using individual Human High Sensitivity ELISA kits (Diaclone, Besaçon, Cedex, France) following the manufacturer’s instructions. Intra-assay and inter-assay reproducibility were < 5% and < 10%, respectively. The rate of cytokine production was calculated by its determination in the cell culture after 2 h of incubation. The amount of cytokine present divided by the counts of PBMCs and by the time of incubation was considered the rate of cytokine production (pg/min/106).

2.9. Statistical Analysis

Statistical analysis was carried out using Statistical Package for Social Sciences (SPSS v.21.0 for Windows0 (IBM Software Group, Chicago, IL, USA). Results in figures and tables are expressed as mean ± SEM and p values < 0.05 were considered statistically significant. Student’s t-test for paired data was used to determine the effects of the GOX treatments (high GOX treatments with respect to control, and low GOX treatments with respect to control) in gene expression and cytokine production. One-way ANOVA was performed to determine differences in H2O2 production between groups and cell viability between treatments.

3. Results

Participants in the study were 34 men and women with documented metabolic syndrome. Anthropometric and haematological characteristics are shown in Table 2. The participants were obese (BMI higher than 30) with values of glucose, cholesterol, and triglycerides borderline to pathological cut off values. The blood cell counts were into the normal distribution of healthy subjects.
Figure 3 shows the progression at different times of H2O2 levels in the immune cells culture medium in the control and after the addition of high and low GOX. The cell counts in the cellular culture were the same as in blood (3.1 ± 0.2 × 103 PBMCs/mm3, and 3.9 ± 0.3 × 103 neutrophils/mm3). When no GOX was added to the culture medium (control situation), PBMCs attained a H2O2 steady state at 400 ± 60 µM, while neutrophils attained steady-state H2O2 levels at 95 ± 8 µM. The H2O2 steady state was reached within the first 10 min of PBMCs or neutrophils incubation and it is stable for 2 h. The concentration of H2O2 in the culture medium reaches the steady state levels at different times and levels depending on the dosage of GOX applied and on the cell type. Neutrophils reach the steady state after 30 min of high GOX addition, while for PBMCs it takes almost 70 min. The steady state was attained after 10 min by neutrophils and after 30 min by PBMCs in the case of low GOX exposure. The H2O2 steady state levels were different for neutrophils and for PBMCs at low and high GOX. The stationary state H2O2 levels were 1400 ± 154 µM with high GOX concentration (1 µg solid GOX/mL culture media) in PBMCs whereas the steady state levels for neutrophils with high GOX concentration (15 µg solid GOX/mL culture medium) were 500 ± 50 µM. The stationary state H2O2 levels were 500 ± 75 µM with low GOX concentration (0.1 µg solid GOX/mL culture medium) in PBMCs whereas the steady state levels for neutrophils with low GOX concentration (5 µg solid GOX/mL culture medium) was 180 ± 40 µM.
The continuous H2O2 production at a high or low rate by GOX addition to the culture medium significantly influenced the PBMCs and neutrophils H2O2 production following LPS or ZYM stimulation (Table 3). Neutrophils produced H2O2 on a cellular basis at a higher rate than PBMCs, under both LPS and ZYM stimuli and even previously or after the treatment with high or low H2O2 (significances not shown). The H2O2 production rate was higher under ZYM stimuli than LPS stimuli, in both PBMCs and neutrophils and independently of the H2O2 concentration (significances not shown). Previous incubation of PBMCs with high or low GOX dosages significantly decreased the rate of H2O2 production after ZYM but not after LPS stimulation. No significant effects were found when neutrophils previously incubated in the presence of GOX were stimulated with ZYM. However, when LPS was used as stimulus, high GOX concentration exposure significantly augmented H2O2 production with respect to the control.
The effects of 2 h of incubation with GOX on the production of cytokines by PBMCs and neutrophils were analyzed (Table 4). The rate of adiponectin production in PBMCs [46] significantly increased only after high GOX dosage. On the contrary, both GOX treatments provoked a significant decrease in IL-6 production, while TNFα levels remained constant, independent of the concentration of GOX applied studied in PBMCs.
In neutrophils, no adiponectin production was detected at all, confirming the inability of this cellular type to synthesize this adipokine. IL-6 and TNFα production remained changeless under H2O2 exposure in neutrophils.
Changes in gene expression in PBMCs and neutrophils were studied after continuous exposure to two different concentrations of H2O2 produced by two different dosages of GOX (Figure 3 and Figure 4). The expression of genes encoding immune and inflammatory-related proteins (COX2, NFkB, TNFα, IL6, IL1β, IL1α, IL8, TLR2, TLR4), antioxidant enzymes (CAT, SOD Cu/Zn, SOD Mn), and mitochondrial dynamics-related proteins (Mtf1, Mtf2, Tfam, and NRF2) were analysed.
In PBMCs (Figure 4) high H2O2 exposure significantly increased the expression of immune and inflammatory-related proteins as IL1β and TLR2, while it provoked a decrease in the expression of SOD Cu/Zn, Mtf1 and Tfam. Low H2O2 exposure promoted a rise in the expression of mitochondrial proteins Tfam, NRF2, and Mtf2 and proinflammatory mediators IL6 and IL8, while it diminished the expression of receptors TLR2 and TLR4. Significant differences between the two high and low GOX treatments were also detected in IL8, NRF2, and Tfam that increased their mRNA expression in low with respect to high GOX treatments.
In neutrophils (Figure 5), the continuous production of high or low extracellular H2O2 exerted a lower influence than in PBMCs on the expression of inflammatory, mitochondrial dynamics, and antioxidant genes. In fact, a low and high rate of H2O2 production maintained the control expression of inflammatory genes, such as NFkB, TNFα, IL1rα, IL1β, IL6, IL8, and TLR2, and the control expression of antioxidant and mitochondrial dynamics genes such as SOD Cu/Zn, SODMn, Mtf1, Mtf2, and Tfam. Only the expression of COX2, TLR4, and NRF2 evidenced a significant influence of the exposition to high or low H2O2 production in neutrophils. High H2O2 production significantly increased the COX2 expression but decreased the expression of NRF2, whereas the low H2O2 production significantly increased the expression of TLR4 in neutrophils.

4. Discussion

A relevant feature of this study is that neutrophils, in spite of being stimulated with higher GOX concentrations than PBMCs, apparently exhibit a steady state of H2O2 levels three times lower than PBMCs during exposure to both GOX concentrations. Furthermore, neutrophils reach the steady state three times faster than PBMCs. These facts reveal a higher capacity of neutrophils to eliminate H2O2 than PBMCs [47]. The method developed is useful to maintain cells to an extracellular sustained production of H2O2 and to reach a steady state of H2O2 levels in the culture media in less than 2 h. Phagocytes (neutrophils, macrophages, monocytes, and eosinophils) contribute to the plasma H2O2 pool [48], whereas the H2O2 generated in the plasma or on the surface of cells can actually enter cells, through aquaporins [49], where there are several enzymes that can eliminate it very rapidly [50]. We observe that isolated PBMCs or neutrophils in culture produce and eliminate H2O2 to quickly attain a cell-dependent steady state. It is also relevant that both PBMCs and neutrophils in culture reach a steady state at a micromolar H2O2 level, being higher in PBMCs than in neutrophils. We also observe that the capabilities of H2O2 production by PBMCs under stimulation with ZYM or LPS are in a similar order to Neutrophils when no GOX is added. Thus, the capabilities to eliminate H2O2, taking into account the H2O2 scavenging enzyme activities, are higher in neutrophils than in PBMCs [51,52,53]. These characteristics are coincident with a H2O2 steady state at higher H2O2 levels in PBMCs than neutrophils. The H2O2 steady state in human blood is difficult to determine but it ranges from a possible low of 0.25 μM to a probable normal range of 1–5 μM, and a high range of 30–50 μM in certain disease states or during chronic inflammation [48]. The H2O2 steady state in PBMCs or neutrophils in culture in our study are about 400 μM or 95 μM respectively, being higher than in plasma, probably due to the lack of plasma scavenging antioxidant enzymes in the culture media such as plasma catalase. Basal cytosolic steady-state H2O2 concentrations are estimated to be lying in the low nanomolar range (≈ 1–10 nM) [20], while during oxidative signalling events H2O2 levels can rise transiently to the upper nanomolar range (≈ 500–700 nM) [54]. The intracellular H2O2 levels in PBMCs and neutrophils are not determined in the present experience but the H2O2 steady state attained in the culture using different GOX levels is at micromolar level. Despite the fact that exogenous in vivo H2O2 concentrations rarely exceed the low-micromolar range (up to 10 µM), studies can be performed with H2O2 levels in the upper micromolar or even millimolar range to obtain cellular responses [28]. The capabilities to scavenge H2O2 by PBMCs and neutrophils are very high and this fact could prevent the intracellular H2O2 from rising to toxicological levels, at least in the control and low H2O2 steady state levels. In fact, in all cases, we do not detect any effects of H2O2 on the cell viability. This is in accordance with a low rate of oxidative protein damage in neutrophils after oxidative insults as hypoxia/reoxygenation in apnoea diving [55] or after acute intense physical activity in trained athletes [56].
An optimal level of inflammation is required for immunity enhancement while chronic inflammation is associated with several metabolic disorders like type 2 diabetes, overweight, and obesity. Indeed, the latter is characterized by chronic low-grade inflammation with permanently increased oxidative stress [7,8,57,58]. This pathological condition normally leads to low levels of plasmatic adiponectin (with anti-inflammatory properties) and high levels of TNFα and IL6 (pro-inflammatory) [59]. Adiponectin is one of the most abundantly secreted adipose tissue proteins that is negatively correlated with obesity; the expression of the anti-inflammatory adiponectin is reduced in adipose tissue of obese individuals compared to lean individuals [60,61]. Previous research showed that adiponectin can reduce the secretion of markers involved in the activation of NFκB including TNF-α, IL-6 by adipocytes and macrophages through TLRs [62]. We observed that IL6 production decreases while the adiponectin secretion concurrently increases as a result of exposure to H2O2 in PBMCs. This fact could be related to direct or indirect anti-inflammatory proprieties of H2O2 [63,64,65]. We also evidence that PBMCs secrete adiponectin, as documented before, [46] and it is increased by the different GOX treatments.
The observed increase in H2O2 production by immune cells after immunostimulatory exposure could be a multifactorial response derived from the increased cellular metabolism induced by the immune activation, and it is probably cell type-dependent. The higher rate of production of H2O2 observed in neutrophils than in PBMCs after LPS or ZYM stimulation, could be a consequence of the two mitochondrial and lysosomal pathways of oxidant species generation in neutrophils [66,67,68] versus the only mitochondrial pathway in PBMCs [69,70]. LPS exerts its action mainly through interaction with TLR4 [71] whereas ZYM directly binds TLR2 [72]. The H2O2 production is higher under ZYM stimuli than LPS stimuli, in both PBMCs and neutrophils, likely indicating a higher reception by TLR2 than the TLR4 way. However, the effects of the GOX treatments on the expression of TLR2 and TLR4 in PBMC and neutrophils are not coincident with the effects of GOX treatments on H2O2 production after immune stimulation. It may be possible to internalize the receptor TLR4 in the membrane in a physiological situation with high H2O2 production rate, such as acute physical activity [73], and, thus, make the TLRs less available for immunostimulators recognition. The observed effects after the LPS and ZYM immune stimulation in terms of ROS production could also be attributable to an action subsequent to the interaction of immunostimulators with TLRs receptors such as the activation of the NFκβ pathway or even at mitochondrial or lysosomal levels [74].
The results obtained reveal that the 2 h exposure of PBMCs and neutrophils to different levels H2O2 produced by a high and low dosage of GOX from patients with metabolic syndrome induce dissimilar changes in these cellular types, with a more resistance of neutrophils to H2O2 effects in terms of gene expression than PBMCs. In PBMCs, expression of proinflammatory proteins IL6, IL8, and IL1β augment after the 2 h incubation with GOX; this pattern in PBMCs suggests that chronic exposure to H2O2, either high or low production rate, promotes a transient inflammatory response in immune cells. Mtf2, a mediator of mitochondrial fusion, also exhibits increased expression after H2O2 incubation, pointing out an emerging role of mitochondrial dynamics-related proteins in inflammation processes. Indeed, it has been reported that Mtf2 interacts with NLRP3 and enhances inflammasome activation, a multiproteic complex responsible for activation for inflammatory processes [75]. Mounting evidence suggests that the involvement of Mtf2 in multiple signalling pathways is not only restricted to the regulation of mitochondrial shape [76].
H2O2 exposure at low GOX dosage activates the expression of Mtf2 and Tfam in PBMCs and puts in evidence the induction of mitochondrial remodelling and biogenesis by H2O2. Conversely, high H2O2 exposure reduces the gene expression of Mtf1 and Tfam in PBMCs. The mitochondrial biogenesis might be considered as an antioxidant mechanism to avoid oxidative stress and also a protective quality-control process for mitochondria [77,78,79]; mitochondria being one of the main sites of ROS production. Mitochondrial fusion and fission in conjunction with mitochondrial autophagy preserve and control organelle quality [80].
The antioxidant enzymatic mechanisms are apparently unaffected in neutrophils and lightly inhibited after H2O2 exposure in PBMCs. The effects of H2O2 on the antioxidant enzymes expression are dependent on the dosage of H2O2 [36]. PBMCs exhibit a decrease in the expression of Cu/Zn SOD at high H2O2 exposure while the other antioxidant enzymes are not affected. Neutrophils seem to be more resistant to the effects of H2O2 on the gene expression of antioxidant enzyme and mitochondrial proteins than PBMCs. Neutrophils are more resistant cells towards oxidative damage than PBMCs [81,82,83]; in fact, we had to apply higher glucose oxidase concentrations to these cell types to induce oxidative stress. The treatment with high GOX reduces the expression of NRF2 in neutrophils. NRF2, also called GABPA [84], functions as a transcription factor that activates the expression of some key metabolic genes regulating cellular growth and nuclear genes required for mitochondrial respiration as well as mitochondrial biogenesis, DNA transcription and replication [85,86,87]. The decreased NRF2 expression induced by high H2O2 exposure could influence mitochondrial respiration in neutrophils. In addition, the treatment with high H2O2 increases the expression of COX2, an inducible enzyme responsible for synthesizing pro-inflammatory prostaglandins from araquidonic acid and resolving-inflammation molecules as resolvins from eicosapentaenoic and docosahexaenoic acid [88,89].
This fact put in evidence a possible pro-inflammatory effect of exposure to high levels of H2O2 in neutrophils.
To sum up, the dosage of exposure to H2O2 seems to represent a key variable that influences the side of the double-edged role of this oxidant species at any given moment: Different H2O2 extracellular levels influence the pro/anti-inflammatory, pro/antioxidant, and mitochondrial status in the cells. Therefore, a close control of these levels may have medical relevance in terms of diagnosis/prognosis of diseases with altered inflammatory and oxidative status as metabolic syndrome.

5. Conclusions

Neutrophils exhibit higher capacity than PBMCs to eliminate H2O2 extracellularly produced by glucose oxidase in a medium with glucose. The exogenous H2O2 exposure of immune cells from patients with metabolic syndrome induce dissimilar changes in these cellular types, with a greater resistance of neutrophils to H2O2 effects in terms of gene expression than PBMCs. Indeed, H2O2, constantly produced (e.g., for 2 h) and ex vivo controlled, triggers a transient anti-inflammatory adipokine secretion in PBMCs but acts as a genetic stimulator of proinflammatory genes in both PBMCs and neutrophils. Antioxidant defences are downregulated by high H2O2 levels in PBMCs but cushioned in neutrophils. H2O2 influences on mitochondrial dynamics related protein gene expression. At a low production rate, H2O2 promotes biogenesis and remodelling mitochondria which might be considered as a hormetic protective quality-control process towards oxidative stress; meanwhile, a high H2O2 production rate induces the downregulation of mitochondrial biogenesis and structural remodelling. A close control of H2O2 levels may have medical relevance in pathological processes with altered inflammatory and oxidative status as metabolic syndrome.

Author Contributions

A.S., A.P. and J.A.T. conceived and designed the experiments; C.B.-C., X.C., M.D.F., D.M., E.A., C.B. and M.A. performed the experiments; C.B.-C., A.S., and A.P. analyzed the data; C.B.-C., A.S. and A.P. wrote the paper. All the authors revised and approved the final draft of the manuscript.

Funding

The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish government, Institute of Health Carlos III (ISCIII) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (Projects 14/00636 and 17/01827, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038), Grant of support to research groups no. 35/2011, AAEE01/2017, and AAEE26/2017 (Balearic Islands Gov.), and EU Cost ACTION CA16112.

Acknowledgments

The authors hereby acknowledge the PhD grant provided by the University of the Balearic Island to Xavier Capó and the FPI/1648/2014 grant provided by Conselleria d’Educació, Cultura i Universitats, Direcció General d’Universitats i Recerca, Govern de les Illes Balears (Fondo Social Europeo) to Carla Busquets-Cortés. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Khaybullina, Z. Inflammation and oxidative stress: Critical role for metabolic syndrome. J. Vasc. Med. Surg. 2017, 5, 1–3. [Google Scholar] [CrossRef]
  2. Holvoet, P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh. K. Acad. Geneeskd. Belg. 2008, 70, 193–219. [Google Scholar] [PubMed]
  3. Devaraj, S.; Goyal, R.; Jialal, I. Inflammation, oxidative stress, and the metabolic syndrome. US Endocrinol. 2008, 4, 32. [Google Scholar] [CrossRef]
  4. Carrier, A. Metabolic syndrome and oxidative stress: A complex relationship. Antioxid. Redox Signal. 2017, 26, 429–431. [Google Scholar] [CrossRef] [PubMed]
  5. Pecht, T.; Gutman-Tirosh, A.; Bashan, N.; Rudich, A. Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans. Obes. Rev. 2014, 15, 322–337. [Google Scholar] [CrossRef] [PubMed]
  6. Powell, L.A.; Crowe, P.; Kankara, C.; McPeake, J.; McCance, D.R.; Young, I.S.; Trimble, E.R.; McGinty, A. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation. Clin. Sci. 2012, 123, 135–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Ellulu, M.S.; Patimah, I.; Khaza’ai, H.; Rahmat, A.; Abed, Y. Obesity & inflammation: The linking mechanism & the complications. Arch. Med. Sci. 2017, 13, 851–863. [Google Scholar] [CrossRef]
  8. Marseglia, L.; Manti, S.; D’Angelo, G.; Nicotera, A.; Parisi, E.; Di Rosa, G.; Gitto, E.; Arrigo, T. Oxidative stress in obesity: A critical component in human diseases. Int. J. Mol. Sci. 2015, 16, 378–400. [Google Scholar] [CrossRef]
  9. McMurray, F.; Patten, D.A.; Harper, M.E. Reactive oxygen species and oxidative stress in obesity—Recent findings and empirical approaches. Obesity 2016, 24, 2301–2310. [Google Scholar] [CrossRef]
  10. Mittal, M.; Siddiqui, M.; Tran, K.; Reddy, S.; Malik, A. Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxid. Redox Signal. 2014, 20, 1126–1167. [Google Scholar] [CrossRef] [Green Version]
  11. Li, L.; Kang, C.; Zhang, Y. Exercise-induced hormesis and skeletal muscle health. Free Radic. Biol. Med. 2016, 98, 113–122. [Google Scholar] [CrossRef]
  12. Di Marzo, N.; Chisci, E.; Giovannoni, R.; Di Marzo, N.; Chisci, E.; Giovannoni, R. The role of hydrogen peroxide in redox-dependent signaling: Homeostatic and pathological responses in mammalian cells. Cells 2018, 7, 156. [Google Scholar] [CrossRef] [PubMed]
  13. Rhee, S.G. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 2003, 14, 211S–215S. [Google Scholar] [CrossRef]
  14. Halliwell, B.; Clement, M.V.; Long, L.H. Hydrogen peroxide in the human body. FEBS Lett. 2000, 486, 14–17. [Google Scholar] [CrossRef]
  15. Burdon, R.H.; Rice-Evans, C. Free radicals and the regulation of mammalian cell proliferation. Free Radic. Res. Commun. 1989, 6, 345–358. [Google Scholar] [CrossRef]
  16. Huang, B.K.; Sikes, H.D. Quantifying intracellular hydrogen peroxide perturbations in terms of concentration. Redox Biol. 2014, 2, 955–962. [Google Scholar] [CrossRef] [PubMed]
  17. Sies, H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017, 11, 613–619. [Google Scholar] [CrossRef]
  18. Ludovico, P.; Burhans, W.C. Reactive oxygen species, ageing and the hormesis police. FEMS Yeast Res. 2014, 14, 33–39. [Google Scholar] [CrossRef] [PubMed]
  19. Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Harmful and beneficial role of ROS. Oxid. Med. Cell. Longev. 2016, 2016, 1–3. [Google Scholar] [CrossRef] [PubMed]
  20. Aldosari, S.; Awad, M.; Harrington, E.; Sellke, F.; Abid, M. Subcellular Reactive Oxygen Species (ROS) in cardiovascular pathophysiology. Antioxidants 2018, 7, 14. [Google Scholar] [CrossRef] [PubMed]
  21. Castro, J.P.; Grune, T.; Speckmann, B. The two faces of Reactive Oxygen Species (ROS) in adipocyte function and dysfunction. Biol. Chem. 2016, 397, 709–724. [Google Scholar] [CrossRef] [PubMed]
  22. Marinho; Susana, H.; Real, C.; Cyrne, L.; Soares, H.; Antunes, F. Redox biology hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2014, 2, 535–562. [Google Scholar] [CrossRef] [PubMed]
  23. Antunes, F.; Brito, P.M. Quantitative biology of hydrogen peroxide signaling. Redox Biol. 2017, 13, 1–7. [Google Scholar] [CrossRef] [PubMed]
  24. Paulsen, C. Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat. Chem. Biol. 2012, 8, 57–64. [Google Scholar] [CrossRef] [PubMed]
  25. Pan, J.; Carroll, K.S. Chemical biology approaches to study protein cysteine sulfenylation. Biopolymers 2014, 101, 165–172. [Google Scholar] [CrossRef] [PubMed]
  26. Paulsen, C.E.; Carroll, K.S. Cysteine-mediated redox signaling: Chemistry, biology, and tools for discovery. Am. Chem. Soc. 2012, 113, 4633–4679. [Google Scholar] [CrossRef] [PubMed]
  27. Zielonka, J.; Kalyanaraman, B. Small-molecule luminescent probes for the detection of cellular oxidizing and nitrating species. Free Radic Biol. Med. 2018, 128, 3–22. [Google Scholar] [CrossRef] [PubMed]
  28. Sobotta, M.C.; Barata, A.G.; Schmidt, U.; Mueller, S.; Millonig, G.; Dick, T.P. Exposing cells to H2O2: A quantitative comparison between continuous low-dose and one-time high-dose treatments. Free Radic. Biol. Med. 2013, 60, 325–335. [Google Scholar] [CrossRef] [PubMed]
  29. Available online: http://www.predimedplus.com/ (accessed on 4 December 2018).
  30. Available online: http://www.isrctn.com/ISRCTN89898870 (accessed on 4 December 2018).
  31. Alberti, K.G.M.M.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.T.; Loria, C.M.; Smith, S.C. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation 2009, 120, 1640–1645. [Google Scholar] [CrossRef]
  32. Boyum, A. Separation of white blood cells. Nature 1964, 204, 793–794. [Google Scholar] [CrossRef]
  33. Mestre-Alfaro, A.; Ferrer, M.D.; Sureda, A.; Tauler, P.; Marttínez, E.; Bibiloni, M.M.; Micol, V.; Tur, J.A.; Pons, A. Phytoestrogens enhance antioxidant enzymes after swimming exercise and modulate sex hormone plasma levels in female swimmers. Eur. J. Appl. Physiol. 2011, 111, 2281–2294. [Google Scholar] [CrossRef] [PubMed]
  34. Busquets-Cortés, C.; Capó, X.; Martorell, M.; Tur, J.A.; Sureda, A.; Pons, A. Training enhances immune cells mitochondrial biosynthesis, fission, fusion, and their antioxidant capabilities synergistically with dietary docosahexaenoic supplementation. Oxid. Med. Cell. Longev. 2016, 2016, 8950384. [Google Scholar] [CrossRef]
  35. Feoktistova, M.; Geserick, P.; Leverkus, M. Crystal Violet Assay for Determining viability of cultured cells. Cold Spring Harb. Protocols 2016, 2016, prot087379. [Google Scholar] [CrossRef]
  36. Ferrer, M.D.; Sureda, A.; Mestre, A.; Tur, J.A.; Pons, A. The double edge of reactive oxygen species as damaging and signaling molecules in HL60 cell culture. Cell. Physiol. Biochem. 2010, 25, 241–252. [Google Scholar] [CrossRef] [PubMed]
  37. Sureda, A.; Hebling, U.; Pons, A.; Mueller, S.; Sureda, A.; Hebling, U.; Pons, A.; Mueller, S. Extracellular H2O2 and not superoxide determines the compartment-specific activation of transferrin receptor by iron regulatory protein 1. Free Radic Res. 2005, 5762. [Google Scholar] [CrossRef]
  38. Sedgwick, G.W.; Fenton, T.W.; Thompson, J.R. Effect of protein precipitating agents on the recovery of plasma-free amino-acids. Can. J. Anim. Sci. 1991, 71, 953–957. [Google Scholar] [CrossRef]
  39. Arola, L.; Herrera, E.; Alemany, M. A new method for deproteinization of small samples of blood plasma for amino acid determination. Anal. Biochem. 1977, 82, 236–239. [Google Scholar] [CrossRef]
  40. McArdle, F.; Spiers, S.; Aldemir, H.; Vasilaki, A.; Beaver, A.; Iwanejko, L.; McArdle, A.; Jackson, M.J. Preconditioning of skeletal muscle against contraction-induced damage: The role of adaptations to oxidants in mice. J. Physiol. 2004, 561, 233–244. [Google Scholar] [CrossRef]
  41. Capó, X.; Martorell, M.; Sureda, A.; Llompart, I.; Tur, J.A.; Pons, A. Diet supplementation with DHA-enriched food in football players during training season enhances the mitochondrial antioxidant capabilities in blood mononuclear cells. Eur. J. Nutr. 2014, 54, 35–49. [Google Scholar] [CrossRef]
  42. Ferrer, M.D.; Sureda, A.; Batle, J.M.; Tauler, P.; Tur, J.A.; Pons, A. Scuba diving enhances endogenous antioxidant defenses in lymphocytes and neutrophils. Free Radic Res. 2007, 41, 274–281. [Google Scholar] [CrossRef]
  43. Rapacz, M. Reference genes in real-time PCR. J. Appl. Genet. 2013, 391–406. [Google Scholar] [CrossRef]
  44. Capó, X.; Martorell, M.; Sureda, A.; Batle, J.M.; Tur, J.A.; Pons, A. Docosahexaenoic diet supplementation, exercise and temperature affect cytokine production by lipopolysaccharide-stimulated mononuclear cells. J. Physiol. Biochem. 2016, 72, 421–434. [Google Scholar] [CrossRef] [PubMed]
  45. Capó, X.; Martorell, M.; Sureda, A.; Tur, J.A.; Pons, A. Effects of dietary Docosahexaenoic, training and acute exercise on lipid mediators. J. Int. Soc. Sports Nutr. 2016, 13, 16. [Google Scholar] [CrossRef] [PubMed]
  46. Crawford, L.J.A; Peake, R.; Price, S.; Morris, T.C.M.; Irvine, A.E. Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis. J. Leukoc. Biol. 2010, 88, 807–811. [Google Scholar] [CrossRef] [PubMed]
  47. Pantopoulos, K.; Schipper, H. Principles of Free Radical Biomedicine; Nova Science Publishers: Hauppauge, NY, USA, 2014; Volume I, ISBN 9781612097732. [Google Scholar]
  48. Forman, H.J.; Bernardo, A.; Davies, K.J.A. Erratum: Corrigendum to “What is the concentration of hydrogen peroxide in blood and plasma?” (Arch. Biochem. Biophys. (2016) 603 (48–53)). Arch. Biochem. Biophys. 2016, 607, 7. [Google Scholar] [CrossRef] [PubMed]
  49. Bienert, G.P.; Schjoerring, J.K.; Jahn, T.P. Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta Biomembr. 2006, 1758, 994–1003. [Google Scholar] [CrossRef] [PubMed]
  50. Tauler, P.; Aguiló, A.; Guix, P.; Jiménez, F.; Villa, G.; Tur, J.A.; Córdova, A.; Pons Biescas, A. Pre-exercise antioxidant enzyme activities determine the antioxidant enzyme erythrocyte response to exercise. J. Sports Sci. 2005, 23, 5–13. [Google Scholar] [CrossRef]
  51. Tauler, P.; Aguiló, A.; Gimeno, I.; Noguera, A.; Agustí, A.; Tur, J.A.; Pons, A. Differential response of lymphocytes and neutrophils to high intensity physical activity and to vitamin C diet supplementation. Free Radic Res. 2003, 37, 931–938. [Google Scholar] [CrossRef]
  52. Capo, X.; Martorell, M.; Sureda, A.; Tur, J.A.; Pons, A. Effects of docosahexaenoic supplementation and in vitro vitamin C on the oxidative and inflammatory neutrophil response to activation. Oxid. Med. Cell. Longev. 2015, 2015. [Google Scholar] [CrossRef]
  53. Tauler, P.; Aguiló, A.; Gimeno, I.; Guix, P.; Tur, J.A.; Pons, A. Different effects of exercise tests on the antioxidant enzyme activities in lymphocytes and neutrophils. J. Nutr. Biochem. 2004, 15, 479–484. [Google Scholar] [CrossRef]
  54. Stöcker, S.; Van Laer, K.; Mijuskovic, A.; Dick, T.P. The conundrum of hydrogen peroxide signaling and the emerging role of peroxiredoxins as redox relay hubs. Antioxid. Redox Signal. 2017, 28. [Google Scholar] [CrossRef] [PubMed]
  55. Sureda, A.; Batle, J.M.; Tauler, P.; Aguiló, A.; Cases, N.; Tur, J.A.; Pons, A. Hypoxia/reoxygenation and vitamin C intake influence no synthesis and antioxidant defenses of neutrophils. Free Radic Biol. Med. 2004, 37, 1744–1755. [Google Scholar] [CrossRef] [PubMed]
  56. Carrera-Quintanar, L.; Funes, L.; Vicente-Salar, N.; Blasco-Lafarga, C.; Pons, A.; Micol, V.; Roche, E. Effect of polyphenol supplements on redox status of blood cells: A randomized controlled exercise training trial. Eur. J. Nutr. 2015, 54, 1081–1093. [Google Scholar] [CrossRef] [PubMed]
  57. Saltiel, A.R.; Olefsky, J.M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 2017, 127, 4–7. [Google Scholar] [CrossRef] [PubMed]
  58. Monteiro, R.; Azevedo, I. Chronic inflammation in obesity and the metabolic syndrome. Mediat. Inflamm. 2010, 2010. [Google Scholar] [CrossRef] [PubMed]
  59. Upadhyaya, S.; Kadamkode, V.; Mahammed, R.; Doraiswami, C.; Banerjee, G. Adiponectin and IL-6: Mediators of inflammation in progression of healthy to type 2 diabetes in Indian population. Adipocyte 2014, 3, 39–45. [Google Scholar] [CrossRef] [PubMed]
  60. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; et al. Paradoxical decrease of an adipose-specific protein. Biochem. Biophys. Res. Commun. 1999, 257, 79–83. [Google Scholar] [CrossRef] [PubMed]
  61. Kang, Y.E.; Kim, J.M.; Joung, K.H.; Lee, J.H.; You, B.R.; Choi, M.J.; Ryu, M.J.; Ko, Y.B.; Lee, M.A.; Lee, J.; et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS ONE 2016, 11, e0154003. [Google Scholar] [CrossRef]
  62. Sargolzaei, J.; Chamani, E.; Kazemi, T.; Fallah, S.; Soori, H. The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases. Clin. Biochem. 2018, 54, 1–10. [Google Scholar] [CrossRef]
  63. Banerjee, S.; Zmijewski, J.W.; Lorne, E.; Liu, G.; Sha, Y.; Abraham, E. Modulation of SCFβ-TrCP-dependent IκBα ubiquitination by hydrogen peroxide. J. Biol. Chem. 2010, 285, 2665–2675. [Google Scholar] [CrossRef]
  64. Zmijewski, J.W.; Lorne, E.; Zhao, X.; Tsuruta, Y.; Sha, Y.; Liu, G.; Abraham, E. Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am. J. Respir. Crit. Care Med. 2009, 179, 694–704. [Google Scholar] [CrossRef] [PubMed]
  65. Essick, E.E.; Wilson, R.M.; Pimentel, D.R.; Shimano, M.; Baid, S.; Ouchi, N.; Sam, F. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PLoS ONE 2013, 8, e68697. [Google Scholar] [CrossRef] [PubMed]
  66. Gomez-Cabrera, M.C.; Salvador-Pascual, A.; Cabo, H.; Ferrando, B.; Vina, J. Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training? Free Radic Biol. Med. 2015, 86, 37–46. [Google Scholar] [CrossRef] [PubMed]
  67. Robinson, J.M. Phagocytic leukocytes and reactive oxygen species. Histochem. Cell Biol. 2009, 131, 465–469. [Google Scholar] [CrossRef] [PubMed]
  68. Segal, A.W. Europe PMC funders group how neutrophils kill microbes. Ann. Rev. Immunol. 2007, 2. [Google Scholar] [CrossRef]
  69. Dan Dunn, J.; Alvarez, L.A.J.; Zhang, X.; Soldati, T. Reactive oxygen species and mitochondria: A nexus of cellular homeostasis. Redox Biol. 2015, 6, 472–485. [Google Scholar] [CrossRef] [PubMed]
  70. Zorov, D.B.; Juhaszova, M.; Sollott, S.J. Mitochondrial Reactive Oxygen Species (ROS) and ROS-induced ROS release. Physiol. Rev. 2014, 94, 909–950. [Google Scholar] [CrossRef] [PubMed]
  71. Pålsson-McDermott, E.M.; O’Neill, L.A.J. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 2004, 113, 153–162. [Google Scholar] [CrossRef]
  72. Sato, M.; Sano, H.; Iwaki, D.; Kudo, K.; Konishi, M.; Takahashi, H.; Takahashi, T.; Imaizumi, H.; Asai, Y.; Kuroki, Y. Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-B activation and TNF-secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 2003, 171, 417–425. [Google Scholar] [CrossRef]
  73. Gleeson, M.; McFarlin, B.; Flynn, M. Exercise and Toll-like receptors. Exerc. Immunol. Rev. 2006, 12, 34–53. [Google Scholar]
  74. Tanaka, S.I.; Isoda, F.; Ishihara, Y.; Kimura, M.; Yamakawa, T. T lymphopaenia in relation to body mass index and TNF-α in human obesity: Adequate weight reduction can be corrective. Clin. Endocrinol. 2001, 54, 347–354. [Google Scholar] [CrossRef]
  75. Ichinohe, T.; Yamazaki, T.; Koshiba, T.; Yanagi, Y. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. USA 2013, 110, 17963–17968. [Google Scholar] [CrossRef] [PubMed]
  76. De Brito, O.M.; Scorrano, L. Mitofusin 2: A mitochondria-shaping protein with signaling roles beyond fusion. Antioxid. Redox Signal. 2008, 10, 621–634. [Google Scholar] [CrossRef] [PubMed]
  77. Cartoni, R.; Leger, B.; Hock, M.B.; Praz, M.; Crettenand, A.; Pich, S.; Ziltener, J.L.; Luthi, F.; Deriaz, O.; Zorzano, A.; et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567, 349–358. [Google Scholar] [CrossRef] [PubMed]
  78. Ishihara, N. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell Sci. 2004, 117, 6535–6546. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Yoboue, E.D.; Mougeolle, A.; Kaiser, L.; Averet, N.; Rigoulet, M.; Devin, A. The role of mitochondrial biogenesis and ROS in the control of energy supply in proliferating cells. Biochim. Biophys. Acta. 2014, 1837, 1093–1098. [Google Scholar] [CrossRef] [PubMed]
  80. Romanello, V.; Sandri, M. Mitochondrial quality control and muscle mass maintenance. Front. Physiol. 2015, 6, 422. [Google Scholar] [CrossRef] [PubMed]
  81. Tauler, P.; Sureda, A.; Cases, N.; Aguiló, A.; Rodríguez-Marroyo, J.A.; Villa, G.; Tur, J.A.; Pons, A. Increased lymphocyte antioxidant defences in response to exhaustive exercise do not prevent oxidative damage. J. Nutr. Biochem. 2006, 17, 665–671. [Google Scholar] [CrossRef]
  82. Ferrer, M.D.; Tauler, P.; Sureda, A.; Pujol, P.; Drobnic, F.; Tur, J.A.; Pons, A. A soccer match’s ability to enhance lymphocyte capability to produce ROS and induce oxidative damage. Int. J. Sport Nutr. Exerc. Metabol. 2009, 19, 243–258. [Google Scholar] [CrossRef]
  83. Sureda, A.; Ferrer, M.D.; Tauler, P.; Romaguera, D.; Drobnic, F.; Pujol, P.; Tur, J.A.; Pons, A. Effects of exercise intensity on lymphocyte H2O2 production and antioxidant defences in soccer players. Br. J. Sports Med. 2007, 43, 186–190. [Google Scholar] [CrossRef]
  84. Baldelli, S.; Aquilano, K.; Ciriolo, M.R. Punctum on two different transcription factors regulated by PGC-1α: Nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2. Biochim. Biophys. Acta Gener. Subj. 2013, 1830, 4137–4146. [Google Scholar] [CrossRef] [PubMed]
  85. Bruni, F.; Polosa, P.L.; Gadaleta, M.N.; Cantatore, P.; Roberti, M. Nuclear respiratory factor 2 induces the expression of many but not all human proteins acting in mitochondrial DNA transcription and replication. J. Biol. Chem. 2010, 285, 3939–3948. [Google Scholar] [CrossRef] [PubMed]
  86. Yang, Z.-F.; Drumea, K.; Mott, S.; Wang, J.; Rosmarin, A.G. GABP Transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis. Mol. Cell. Biol. 2014, 34, 3194–3201. [Google Scholar] [CrossRef]
  87. Putti, R.; Sica, R.; Migliaccio, V.; Lionetti, L. Diet impact on mitochondrial bioenergetics and dynamics. Front. Physiol. 2015, 6, 1–7. [Google Scholar] [CrossRef] [PubMed]
  88. Ferrer, M.D.; Busquests-Cortes, C.; Capo, X.; Tejada, S.; Tur, J.A.; Pons, A.; Sureda, A. Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr. Med. Chem. 2018, 25, 1–15. [Google Scholar] [CrossRef] [PubMed]
  89. Capó, X.; Martorell, M.; Busquets-Cortés, C.; Tejada, S.; Tur, J.A.; Pons, A.; Sureda, A. Resolvins as proresolving inflammatory mediators in cardiovascular disease. Eur. J. Med. Chem. 2018, 153. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Balance between hydrogen peroxide production and elimination: H2O2 extracellularly produced by glucose oxidase in the presence of glucose can be intracellularly decomposed by numerous antioxidant systems within the immune cells. GOX: Glucose oxidase; CAT: Catalase; GPx: Glutathione peroxidase; TRx-Px: Thioredoxin peroxidase; MPO: Myeloperoxidase; GSH: Reduced glutathione; GSSG: Oxidized glutathione; Trx(SH)2: Oxidized thioredoxin; Trx-S2: Reduced thioredoxin; Cl: Chloride anion; HClO: Hypochlorous acid.
Figure 1. Balance between hydrogen peroxide production and elimination: H2O2 extracellularly produced by glucose oxidase in the presence of glucose can be intracellularly decomposed by numerous antioxidant systems within the immune cells. GOX: Glucose oxidase; CAT: Catalase; GPx: Glutathione peroxidase; TRx-Px: Thioredoxin peroxidase; MPO: Myeloperoxidase; GSH: Reduced glutathione; GSSG: Oxidized glutathione; Trx(SH)2: Oxidized thioredoxin; Trx-S2: Reduced thioredoxin; Cl: Chloride anion; HClO: Hypochlorous acid.
Nutrients 10 01920 g001
Figure 2. Peripheral blood mononuclear cells (PBMCs) and neutrophils viability after 2 h of exposure to a high and low dosage of H2O2 at 37 °C. Statistical analysis: One way ANOVA, p < 0.05. PBMCs: 1 and 0.1 µg solid GOX/mL (high and low, respectively). Neutrophils: 15 and 5 µg solid GOX/mL (high and low, respectively). Control: no GOX added.
Figure 2. Peripheral blood mononuclear cells (PBMCs) and neutrophils viability after 2 h of exposure to a high and low dosage of H2O2 at 37 °C. Statistical analysis: One way ANOVA, p < 0.05. PBMCs: 1 and 0.1 µg solid GOX/mL (high and low, respectively). Neutrophils: 15 and 5 µg solid GOX/mL (high and low, respectively). Control: no GOX added.
Nutrients 10 01920 g002
Figure 3. Levels of H2O2 in the culture medium of PBMCs and neutrophils in the control and after high and low H2O2 exposure by GOX addition for 2 h at 37 °C. PBMCs: High indicates H2O2 production rate by 1 µg solid GOX/mL culture medium and Low indicates H2O2 production rate by 0.1 µg solid GOX/mL culture medium. Neutrophils: High indicates H2O2 production rate by 15 µg solid GOX/mL culture medium and Low indicates H2O2 production rate by 5 µg solid GOX/mL culture medium. Control indicates PBMCs or neutrophils are cultured in the medium without GOX addition.
Figure 3. Levels of H2O2 in the culture medium of PBMCs and neutrophils in the control and after high and low H2O2 exposure by GOX addition for 2 h at 37 °C. PBMCs: High indicates H2O2 production rate by 1 µg solid GOX/mL culture medium and Low indicates H2O2 production rate by 0.1 µg solid GOX/mL culture medium. Neutrophils: High indicates H2O2 production rate by 15 µg solid GOX/mL culture medium and Low indicates H2O2 production rate by 5 µg solid GOX/mL culture medium. Control indicates PBMCs or neutrophils are cultured in the medium without GOX addition.
Nutrients 10 01920 g003
Figure 4. Relative gene expression of pro/anti-inflammatory proteins, antioxidant enzymes and mitochondrial dynamics related proteins in PBMCs. Ribosomal 18S as a reference. Control was arbitrarily referred to as 1. (Control: only cells present in the medium; high: 1 µg solid GOX/mL; low: 0.1 µg solid GOX/mL). Statistical analysis: Student’s t-test for paired data, p < 0.05. (*) Significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control; (#) Significant effects between the high treatment and the low treatment.
Figure 4. Relative gene expression of pro/anti-inflammatory proteins, antioxidant enzymes and mitochondrial dynamics related proteins in PBMCs. Ribosomal 18S as a reference. Control was arbitrarily referred to as 1. (Control: only cells present in the medium; high: 1 µg solid GOX/mL; low: 0.1 µg solid GOX/mL). Statistical analysis: Student’s t-test for paired data, p < 0.05. (*) Significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control; (#) Significant effects between the high treatment and the low treatment.
Nutrients 10 01920 g004
Figure 5. Relative expression of pro/anti-inflammatory proteins, antioxidant enzymes (A,B), and mitochondrial dynamics related proteins (C) in neutrophils Ribosomal 18S as a reference (Control: Only cells present in the medium; High: 15 µg solid GOX/mL; Low: 5 µg solid GOX/mL). Statistical analysis: Student’s t-test for paired data, p < 0.05. (*)Significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control.
Figure 5. Relative expression of pro/anti-inflammatory proteins, antioxidant enzymes (A,B), and mitochondrial dynamics related proteins (C) in neutrophils Ribosomal 18S as a reference (Control: Only cells present in the medium; High: 15 µg solid GOX/mL; Low: 5 µg solid GOX/mL). Statistical analysis: Student’s t-test for paired data, p < 0.05. (*)Significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control.
Nutrients 10 01920 g005
Table 1. Primer sequence and annealing temperatures used for the real-time PCR.
Table 1. Primer sequence and annealing temperatures used for the real-time PCR.
GenePrimerTemp
18SFw:5′-GACTCAACACGGGAAACCCTCAC-3′60 °C
Rv:5′-GACTCAACACGGGAAACCCTCAC-3′
COX2Fw:5′-TTGCCTGGCAGGGTTGCTGGTGGTA-3′67 °C
Rv:5′-CATCTGCCTGCTCTGGTCAATGGAA-3′
CATFw:5′-TTT GGC TAC TTT GAG GTC AC-3′60 °C
Rv:5′-TCC CCA TTT GCA TTA ACC AG-3′
TNFαFw:5′-CCCAGGCAGTCAGATCATCTTCTCGGAA-3′63 °C
Rv:5′-CTGGTTATCTCTCAGCTCCACGCCATT-3′
IL6Fw:5′-TACATCCTCGACGGCATCTC-3′63 °C
Rv:5′-ACTCATCTGCACAGCTCTGG-3′
IL1βFw:5′-GGACAGGATATGGAGCAACA-3′58 °C
Rv:5′-GGCAGACTCAAATTCCAGCT-3′
IL8Fw:5′-GCTCTGTGTGAAGGTGCAGTTTTGCCAA-3′63 °C
Rv:5′-TGAACATGGGGAGTGTTTCA-3′
NFkBFw:5′-AAACACTGTGAGGATGGGATCTG-3′60 °C
Rv:5′-CGAAGCCGACCACCATGT-3′
IL10Fw:5′-AGAACCTGAAGACCCTCAGGC-3′58 °C
Rv:5′-CCACGGCCTTGCTCTTGTT-3′
Mfn1Fw:5′-TGTTTTGGTCGCAAACTCTG-3′60 °C
Rv:5′-CTGTCTGCGTACGTCTTCCA-3′
Mfn2Fw:5′-ATGCATCCCCACTTAAGCAC-3′60 °C
Rv:5′-CCAGAGGGCAGAACTTTGTC-3′
TfamFw:5′-CAAGACAGATGAAACCACCTC-3′60 °C
Rv:5′-AGATTGGGGTCGGGTCACT-3′
NRF2Fw:5′-GCGACGGAAAGAGTATGAGC-3′60 °C
Rv:5′-GTTGGCAGATCCACTGGTTT-3′
TLR2Fw:5′-GGGTTGGAAGCACTGGACAAT-3′55 °C
Rv:5′-TTCTTCCTTGGAGAGGCTGA-3′
TLR4Fw:5′-GGTCACCTTTTCTTGATTCCA-3′55 °C
Rv:5′-TCAGAGGTCCATCAAACATCAC-3′
SOD Cu/ZnFw:5′-TCA GGA GAC CAT TGC ATC ATT-3′63 °C
Rv:5′-CGC TTT CCT GTC TTT GTA CTT TCT TC-3′
SOD MnFw:5′-GAGAAGGTACCAGGAGGCGTTG-3′64 °C
Rv:CAAGCCAACCCCAACCTGAGC-3′
18S: Ribosomal 18S; COX2: Cyclooxigenase 2; CAT: catalase; TNFα: Tumor necrosis factor alpha; IL6: Interleukin 6; IL1β: Interleukin 1β; IL8: Interleukin 8; NFkB: Nuclear factor kappa-light-chain-enhancer of activated B cells; IL10: Interleukin 10; Mfn1, Mitofusin 1; Mfn2, Mitofusin 2; Tfam: Transcription factor A, mitochondrial; NRF2: Nuclear respiratory factor 2; TLR2: toll-like Receptor 2; TLR4: Toll-like receptor 4; SOD Cu/Zn: Copper/zinc superoxide dismutase; SOD Mn: manganese superoxide dismutase.
Table 2. Anthropometric and haematological characteristics of the participants.
Table 2. Anthropometric and haematological characteristics of the participants.
(N = 34)Reference Value
Age (years)64.2 ± 0.71
Weight (kg)85.5 ± 1.91
Height (height)164.3 ± 1.41
Waist circumference (cm)107.5 ± 1.31
BMI (kg/m2)31.6 ± 0.51
Glucose (mg/dL)112.6 ± 3.176–110
Triglycerydes (mg/dL)155.9 ± 9.110–150
Total cholesterol (mg/dL)198.8 ± 6.1<200
PBMCs (103 cells/mm3)3.1 ± 0.21
Lymphocytes (103 cells/mm3)2.5 ± 0.11–5
Monocytes (103 cells/mm3)0.6 ± 0.010–0.8
Neutrophils (103 cells/mm3)3.9 ± 0.31.8–7.7
Cell viability after GOX addition, and consequent H2O2 generation in the culture medium, was assessed. Results are shown in Figure 2. No significant changes were observed in cell viability when cells were treated with high and low GOX concentrations with respect to control conditions (no GOX present in the medium). 1 No reference value for this parameter.
Table 3. H2O2 production by PBMCs and neutrophils stimulated with LPS or ZYM after high and low H2O2 treatments.
Table 3. H2O2 production by PBMCs and neutrophils stimulated with LPS or ZYM after high and low H2O2 treatments.
ControlHighLow
nmol H2O2/min/106 cellsPBMCsZYM21.8 ± 3.214.6 ± 2.3 *17.0 ± 2.8 $
LPS63.3 ± 2.79.0 ± 2.28.7 ± 3.1
NeutrophilsZYM62.9 ± 9.362.9 ± 8.363.3 ± 7.4
LPS17.4 ± 2.449.1 ± 7.4 *27.5 ± 5.5
High and Low indicates high and low rate of H2O2 production by high and low level of Glucose oxidase in the medium. Statistical analysis: One way ANOVA, p < 0.05. (*) significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control; LPS: lipopolysaccharide; ZYM: zymosan.
Table 4. Cytokine levels in supernatants of PBMCs and neutrophils samples after 2 h continuous exposure to high and low GOX treatments.
Table 4. Cytokine levels in supernatants of PBMCs and neutrophils samples after 2 h continuous exposure to high and low GOX treatments.
(pg/min/106)ControlHighLow
PBMCsAdiponectin61.1 ± 11.992.1 ± 14.7 *83.6 ± 15.7
IL-6116 ± 5112.7 ± 4.7 *38.8 ± 24.6 $
TNFα1587 ± 2201643 ± 2641506 ± 172
NeutrophilsAdiponectinNDNDND
IL-638.3 ± 11.4131.1 ± 8.646.8 ± 15.7
TNFα374 ± 90382 ± 112406 ± 64.6
High and Low indicates high and low rate of H2O2 production by high and low level of Glucose oxidase in the medium. Statistical analysis: Student’s t-test for paired data, p < 0.05. (*) Significant effects between the high treatment and the control; ($) significant effects between the low treatment and the control. ND: Non-detected.

Share and Cite

MDPI and ACS Style

Busquets-Cortés, C.; Capó, X.; Argelich, E.; Ferrer, M.D.; Mateos, D.; Bouzas, C.; Abbate, M.; Tur, J.A.; Sureda, A.; Pons, A. Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome. Nutrients 2018, 10, 1920. https://0-doi-org.brum.beds.ac.uk/10.3390/nu10121920

AMA Style

Busquets-Cortés C, Capó X, Argelich E, Ferrer MD, Mateos D, Bouzas C, Abbate M, Tur JA, Sureda A, Pons A. Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome. Nutrients. 2018; 10(12):1920. https://0-doi-org.brum.beds.ac.uk/10.3390/nu10121920

Chicago/Turabian Style

Busquets-Cortés, Carla, Xavier Capó, Emma Argelich, Miguel D. Ferrer, David Mateos, Cristina Bouzas, Manuela Abbate, Josep A. Tur, Antoni Sureda, and Antoni Pons. 2018. "Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome" Nutrients 10, no. 12: 1920. https://0-doi-org.brum.beds.ac.uk/10.3390/nu10121920

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop